Sanofi

New Jersey
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

Sanofi scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Sanofi, a French pharmaceutical company, increases the risk of dividing employees, alienating customers and harming shareholders. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Sanofi forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company provides a benefits package for employees which covers travel/lodging costs for an abortion and transgender medical procedures for covered employees and dependents, including children. Sanofi's CEO signed Catalyst's Champions for Change pledge. America First Legal filed a letter with the EEOC requesting a civil rights investigation into Sanofi over discriminatory practices in hiring. Sanofi is a member of the Global Alliance for Responsible Media. The company provides a benefits package for employees which covers travel/lodging costs for an abortion and offers "Challenge your Bias" trainings. Sanofi supports the Equality Act and is a corporate partner of the National LGBT Chamber of Commerce. The company signed the Health Sector Climate Pledge, committing itself to achieve net zero emissions by 2050. For these reasons, Sanofi receives a High Risk rating.

View Full Report
Generate Reports
Clear
Toast